PFA
JAZZ icon

Professional Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Professional Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed – – 482
2022
Q1 		$0 Hold
3
– – ﹤0.01% 489
2021
Q4 		$0 Hold
3
– – ﹤0.01% 469
2021
Q3 		$0 Hold
3
– – ﹤0.01% 415
2021
Q2 		$1K Buy
+3
New +$520 ﹤0.01% 388

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Professional Financial Advisors's JAZZ Position: Q2 2022 in Review

Professional Financial Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2022, closing a stake of 3 shares.

Professional Financial Advisors first reported a position in JAZZ in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q2 2021. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

  • Professional Financial Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Professional Financial Advisors sold 3 Jazz Pharmaceuticals shares in Q2 2022.
  • Professional Financial Advisors first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Professional Financial Advisors's Jazz Pharmaceuticals position peaked at $1K in Q2 2021.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on Professional Financial Advisors's 13F filing for Q2 2022, filed 28 Jul 2022.